205 related articles for article (PubMed ID: 28454732)
1. Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy.
Yang Z; Su Z; DeWitt JP; Xie L; Chen Y; Li X; Han L; Li D; Xia J; Zhang Y; Yang Y; Jin C; Zhang J; Li S; Li K; Zhang Z; Qu X; He Z; Chen Y; Shen Y; Ren M; Yuan Z
EBioMedicine; 2017 May; 19():49-59. PubMed ID: 28454732
[TBL] [Abstract][Full Text] [Related]
2. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
[TBL] [Abstract][Full Text] [Related]
3. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis.
Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Inoue M; Nakamura H
Gastroenterology; 2002 Feb; 122(2):308-17. PubMed ID: 11832446
[TBL] [Abstract][Full Text] [Related]
4. Drosophila Lung Cancer Models Identify Trametinib plus Statin as Candidate Therapeutic.
Levine BD; Cagan RL
Cell Rep; 2016 Feb; 14(6):1477-1487. PubMed ID: 26832408
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivo.
Liu H; Wang Z; Li Y; Li W; Chen Y
Neoplasma; 2013; 60(3):240-6. PubMed ID: 23373992
[TBL] [Abstract][Full Text] [Related]
6. [Fluvastatin induces apoptosis on human tongue carcinoma cell line HSC-3].
Fujiwara K; Tsubaki M; Yamazoe Y; Nishiura S; Kawaguchi T; Ogaki M; Nishinobo M; Shimamoto K; Moriyama K; Nishida S
Yakugaku Zasshi; 2008 Jan; 128(1):153-8. PubMed ID: 18176067
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y
J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871
[TBL] [Abstract][Full Text] [Related]
9. Involvement of peptidyl-prolyl isomerase Pin1 in the inhibitory effect of fluvastatin on endothelin-1-induced cardiomyocyte hypertrophy.
Sakai S; Shimojo N; Kimura T; Tajiri K; Maruyama H; Homma S; Kuga K; Mizutani T; Aonuma K; Miyauchi T
Life Sci; 2014 May; 102(2):98-104. PubMed ID: 24657892
[TBL] [Abstract][Full Text] [Related]
10. Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.
Plosker GL; Wagstaff AJ
Drugs; 1996 Mar; 51(3):433-59. PubMed ID: 8882381
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin inhibits intimal hyperplasia in wild-type but not Thbs1-null mice.
Desai P; Helkin A; Odugbesi A; Stein J; Bruch D; Lawler J; Maier KG; Gahtan V
J Surg Res; 2017 Apr; 210():1-7. PubMed ID: 28457315
[TBL] [Abstract][Full Text] [Related]
12. No effect of fluvastatin on the bone mineral density of children with minimal change glomerulonephritis and some focal mesangial cell proliferation, other than an ameliorating effect on their proteinuria.
Kano K; Nishikura K; Yamada Y; Arisaka O
Clin Nephrol; 2005 Feb; 63(2):74-9. PubMed ID: 15730048
[TBL] [Abstract][Full Text] [Related]
13. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
Mascaró C; Ortiz JA; Ramos MM; Haro D; Hegardt FG
Arch Biochem Biophys; 2000 Feb; 374(2):286-92. PubMed ID: 10666309
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
Gao P; Wu X; Shui H; Jia R
J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
[TBL] [Abstract][Full Text] [Related]
15. [Fluvastatin in the treatment of hyperlipoproteinemia, initial experience].
Ceska R
Vnitr Lek; 1996 Aug; 42(8):533-6. PubMed ID: 8967021
[TBL] [Abstract][Full Text] [Related]
16. [Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma].
Gao J; Li JS; Xu GL; Jia WD; Ma JL; Yu JH; Ge YS
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):900-4. PubMed ID: 21205474
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects.
Kolawole EM; McLeod JJ; Ndaw V; Abebayehu D; Barnstein BO; Faber T; Spence AJ; Taruselli M; Paranjape A; Haque TT; Qayum AA; Kazmi QA; Wijesinghe DS; Sturgill JL; Chalfant CE; Straus DB; Oskeritzian CA; Ryan JJ
J Immunol; 2016 Feb; 196(4):1461-70. PubMed ID: 26773154
[TBL] [Abstract][Full Text] [Related]
18. 4-cholesten-3-one suppresses lung adenocarcinoma metastasis by regulating translocation of HMGB1, HIF1α and Caveolin-1.
Ma J; Fu G; Wu J; Han S; Zhang L; Yang M; Yu Y; Zhang M; Lin Y; Wang Y
Cell Death Dis; 2016 Sep; 7(9):e2372. PubMed ID: 27899819
[TBL] [Abstract][Full Text] [Related]
19. ERK5 Activity Prevention Improves the Antitumor Efficacy of Fluvastatin on Thymic Carcinoma.
Hayashi K; Fujita T; Chida M
Anticancer Res; 2024 Jun; 44(6):2511-2515. PubMed ID: 38821590
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]